Outcome of the Board meeting held on 14.08.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Jeevan Scientific Technology Limited approved standalone and consolidated unaudited financial results for Q1 FY26 (quarter ended 30 June 2025). Standalone revenue from operations fell to Rs. 821.57 lakhs from Rs. 1,251.66 lakhs a year earlier, and the company swung to a net loss of Rs. 215.99 lakhs versus a profit of Rs. 160.08 lakhs in Q1 FY25. On a consolidated basis, revenue declined to Rs. 879.91 lakhs with a net loss of Rs. 321.91 lakhs. The Board re-appointed Mr. Krishna Kishore Kuchipudi as Managing Director for 3 years from 1 April 2026 at Rs. 9 lakh per month, appointed Mr. Gollapinni Mallikarjuna (former IRS officer) as an additional independent director, and re-appointed two directors retiring by rotation. Director Mr. Thammareddy Ravi resigned citing personal commitments. The Board also approved the grant of 3,00,000 stock options to employees under the ESOP 2016 scheme and scheduled the AGM for 27 September 2025.
Sharp revenue decline and a return to losses in Q1 FY26 are negative for shareholders, though cost control remains a focus. Board changes are largely routine, with one independent director exit and one new independent addition; the promoter-led MD continues, maintaining leadership continuity.